Zai Lab (ZLAB) EBT Margin Growth (1y) (2021 - 2026)

Zai Lab (ZLAB) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,526.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -683.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 813.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Zai Lab 21.37 Bn 21.37 Bn -34.26 Mn -117,674.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -117,674.00
Dec 31, 2025 9,052.00
Sep 30, 2025 -509,682.00
Jun 30, 2025 1.56 Mn
Mar 31, 2025 1,551.00
Dec 31, 2024 -3,856.00
Sep 30, 2024 5,914.00
Mar 31, 2024 1,690.00
Dec 31, 2023 6,379.00
Sep 30, 2023 18,025.00
Mar 31, 2023 10,001.00
Dec 31, 2022 38,109.00
Jun 30, 2022 15,479.00
Mar 31, 2022 98,128.00
Dec 31, 2021 2,351.00
Jun 30, 2021 28,978.00
Mar 31, 2021 -57,728.00